Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q3 2014 (← Previous) (Next →)

Filing Date: Nov 13, 2014

Total Value: $1.338B (100.0% shares, 0.0% debt)

Holdings (43)

UTHR UNITED THERAPEUTICS CORP DEL 12.5%
Value $167M Shares 1,298,828 Share Price $128.65 * Est. Cost/Share $71.44 Unrealized @ Report Date +44.3%
— AUXILIUM PHARMACEUTICALS INC 10.8%
Value $145M Shares 4,854,631 Share Price $29.85 Est. Cost/Share $17.45 Unrealized @ Report Date —
— CUBIST PHARMACEUTICALS INC 9.1%
Value $122M Shares 1,843,688 Share Price $66.34 Est. Cost/Share $59.40 Unrealized @ Report Date —
BMRN BIOMARIN PHARMACEUTICAL INC 6.8%
Value $91.24M Shares 1,264,397 Share Price $72.16 * Est. Cost/Share $63.78 Unrealized @ Report Date +3.0%
— CYBERONICS INC 6.2%
Value $82.94M Shares 1,621,101 Share Price $51.16 Est. Cost/Share $52.15 Unrealized @ Report Date —
— CLOVIS ONCOLOGY INC 5.8%
Value $78.1M Shares 1,721,757 Share Price $45.36 Est. Cost/Share $45.31 Unrealized @ Report Date —
— ABIOMED INC 4.5%
Value $60.33M Shares 2,429,524 Share Price $24.83 Est. Cost/Share $21.63 Unrealized @ Report Date —
— ANACOR PHARMACEUTICALS INC 3.9%
Value $51.8M Shares 2,116,665 Share Price $24.47 Est. Cost/Share $10.16 Unrealized @ Report Date —
— AMAG PHARMACEUTICALS INC 3.8%
Value $51.52M Shares 1,614,536 Share Price $31.91 Est. Cost/Share $22.29 Unrealized @ Report Date —
INSM INSMED INC 3.8%
Value $50.79M Shares 3,892,199 Share Price $13.05 * Est. Cost/Share $14.73 Unrealized @ Report Date +2.4%
— NPS PHARMACEUTICALS INC 3.3%
Value $44.19M Shares 1,699,562 Share Price $26.00 Est. Cost/Share $27.84 Unrealized @ Report Date —
— KYTHERA BIOPHARMACEUTICALS I 2.7%
Value $36.11M Shares 1,102,181 Share Price $32.76 Est. Cost/Share $37.70 Unrealized @ Report Date —
VNDA VANDA PHARMACEUTICALS INC 2.5%
Value $34.08M Shares 3,283,124 Share Price $10.38 * Est. Cost/Share $7.79 Unrealized @ Report Date +68.3%
— SEQUENOM INC 2.2%
Value $29.14M Shares 9,810,442 Share Price $2.97 Est. Cost/Share $3.91 Unrealized @ Report Date —
STAA STAAR SURGICAL CO 2.1%
Value $27.63M Shares 2,599,553 Share Price $10.63 * Est. Cost/Share $8.10 Unrealized @ Report Date +46.8%
— WRIGHT MED GROUP INC 1.9%
Value $25.23M Shares 832,729 Share Price $30.30 Est. Cost/Share $30.30 Unrealized @ Report Date —
GILD GILEAD SCIENCES INC 1.3%
Value $17.83M Shares 167,500 Share Price $106.45 * Est. Cost/Share $55.18 Unrealized @ Report Date +23.3%
— MOMENTA PHARMACEUTICALS INC 1.2%
Value $16.5M Shares 1,455,176 Share Price $11.34 Est. Cost/Share $14.44 Unrealized @ Report Date —
— SHIRE PLC 1.2%
Value $16.5M Shares 63,700 Share Price $259.04 Est. Cost/Share $233.03 Unrealized @ Report Date —
— ALIMERA SCIENCES INC 1.2%
Value $16.48M Shares 3,040,260 Share Price $5.42 Est. Cost/Share $4.88 Unrealized @ Report Date —
— CELGENE CORP 1.2%
Value $16.26M Shares 171,600 Share Price $94.78 Est. Cost/Share $87.84 Unrealized @ Report Date —
— CELLADON CORP 1.1%
Value $15.24M Shares 1,457,200 Share Price $10.46 Est. Cost/Share $11.92 Unrealized @ Report Date —
EXAS EXACT SCIENCES CORP 1.1%
Value $15.07M Shares 777,676 Share Price $19.38 * Est. Cost/Share $12.83 Unrealized @ Report Date +42.9%
PRTA PROTHENA CORP PLC 1.1%
Value $14.93M Shares 673,818 Share Price $22.16 * Est. Cost/Share $22.22 Unrealized @ Report Date -4.6%
— MEDIVATION INC 1.0%
Value $12.86M Shares 130,100 Share Price $98.87 Est. Cost/Share $78.28 Unrealized @ Report Date —
— ARIAD PHARMACEUTICALS INC 0.9%
Value $12.05M Shares 2,231,717 Share Price $5.40 Est. Cost/Share $6.82 Unrealized @ Report Date —
FOLD AMICUS THERAPEUTICS INC 0.9%
Value $11.64M Shares 1,956,376 Share Price $5.95 * Est. Cost/Share $3.07 Unrealized @ Report Date +70.5%
ALGN ALIGN TECHNOLOGY INC 0.8%
Value $11.01M Shares 213,100 Share Price $51.68 * Est. Cost/Share $52.58 Unrealized @ Report Date +3.6%
— INTUITIVE SURGICAL INC 0.8%
Value $10.74M Shares 23,250 Share Price $461.81 Est. Cost/Share $422.23 Unrealized @ Report Date —
— RIGEL PHARMACEUTICALS INC 0.8%
Value $10.05M Shares 5,180,101 Share Price $1.94 Est. Cost/Share $3.43 Unrealized @ Report Date —
— ACELRX PHARMACEUTICALS INC 0.7%
Value $8.908M Shares 1,622,654 Share Price $5.49 Est. Cost/Share $5.49 Unrealized @ Report Date —
— QLT INC 0.6%
Value $8.344M Shares 1,846,075 Share Price $4.52 Est. Cost/Share $4.40 Unrealized @ Report Date —
— OREXIGEN THERAPEUTICS INC 0.6%
Value $8.227M Shares 1,931,324 Share Price $4.26 Est. Cost/Share $6.46 Unrealized @ Report Date —
— ZELTIQ AESTHETICS INC 0.5%
Value $6.433M Shares 284,249 Share Price $22.63 Est. Cost/Share $22.63 Unrealized @ Report Date —
— XOMA CORP DEL 0.2%
Value $2.631M Shares 624,900 Share Price $4.21 Est. Cost/Share $4.20 Unrealized @ Report Date —
GERN GERON CORP 0.2%
Value $2.323M Shares 1,161,400 Share Price $2.00 * Est. Cost/Share $2.85 Unrealized @ Report Date -13.6%
— HYPERION THERAPEUTICS INC 0.1%
Value $1.581M Shares 62,700 Share Price $25.22 Est. Cost/Share $22.00 Unrealized @ Report Date —
— REVANCE THERAPEUTICS INC 0.1%
Value $1.554M Shares 80,369 Share Price $19.34 Est. Cost/Share $31.50 Unrealized @ Report Date —
— BIOSPECIFICS TECHNOLOGIES CO 0.1%
Value $1.247M Shares 35,336 Share Price $35.29 Est. Cost/Share $32.67 Unrealized @ Report Date —
— AVEO PHARMACEUTICALS INC 0.1%
Value $1.063M Shares 958,026 Share Price $1.11 Est. Cost/Share $2.50 Unrealized @ Report Date —
— SOPHIRIS BIO INC 0.1%
Value $858K Shares 292,900 Share Price $2.93 Est. Cost/Share $3.88 Unrealized @ Report Date —
CYTK CYTOKINETICS INC 0.0%
Value $435K Shares 123,686 Share Price $3.52 * Est. Cost/Share $6.71 Unrealized @ Report Date -37.4%
— MALLINCKRODT PUB LTD CO 0.0%
Value $323K Shares 3,588 Share Price $90.02 Est. Cost/Share $90.02 Unrealized @ Report Date —